Ready to flex your analytic/creative muscles in ways that go beyond what the #JusticeOutcomesExplorer is designed to support? Diff-in-diff regressions? Custom visualizations? Download the full data with a simple registration process and have at it! Let us know what you find!!

Couldn’t ask for a better author team guiding people through this topic

Especially excited to see Theresa Rolley as a coauthor, who taught me most of what I know about caring for hospitalized people who use drugs

BMC Addiction Medicine Fellowship Grayken Center for Addiction

Check it out! I’m a novice at podcasts but loved working with Febrile Sara Dong Ayesha Appa Chasity Tuell on this episode featuring our CID review on harm reduction & shared decision making (Shout out to Alysse Wurcel Jacinda Abdul-Mutakabbir (Dr.JAM) PharmD MPH & team ✨)

Why should Colorado representatives support the Modernizing Opioid Treatment Access Act (M-OTAA)?

We lay out the arguments in a new Op Ed for the The Colorado Sun

Thanks to coauthors Christine Neeb and Jarratt Pytell

coloradosun.com/2024/04/22/opi…

Wooohooo!!! So well deserved, Leslie Suen, MD, MAS

🙌 🎉 🙌

Here's the video of today's event:

finance.senate.gov/hearings/closi…

Special thanks to Senator Ben Cardin and Steve Daines and their staff

Great to be on the panel with Sarah Bagley (she/her) Paul Christine and Malcolm Horn

Proud of Paul Christine and Sarah Bagley (she/her) for testifying this afternoon for the US Senate Finance Committee on how medicare & medicaid can improve SUD care.

BMC Addiction Medicine Fellowship Grayken Center for Addiction Denver Health

finance.senate.gov/hearings/closi…

Honored to have the opportunity to testify alongside my friend Sarah Bagley (she/her) in the Senate Finance Cmte hearing:

'Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs'

Tomorrow at 2:30 pm ET

finance.senate.gov/hearings/closi…

Paul Christine Jane Liebschutz (she/her) & more use examples from a planned study comparing #BuprenorphineNaloxone & extended-release #Naltrexone with #MOUD discontinuation rates to show challenges & approaches to employing target trial emulation in the study of MOUD.

onlinelibrary.wiley.com/doi/10.1111/ad…

SAVE THE DATE: 4/25 4:30-6pm EST

'Strengthening policy implications to improve the impact of drug policy research,' an instructive webinar with Noa Krawczyk

Far too often, policy is overlooked or underdeveloped in papers. Get some tips!

Register: bit.ly/DrugResearchIm…

Thank you KQED Forum for having me on the show yesterday and for highlighting such an important topic of methadone regulation reform and how it's urgently needed to save lives.

In a recent article at Journal of Substance Use & Addiction Tx (JSAT) , Amanda Abraham, Christina Andrews , Colleen Grogan, and I examined how Single State Agencies (SSA) allocated federal, state, and other grants to address the opioid epidemic using survey data from The University of Chicago . (1/4)
sciencedirect.com/science/articl…

Opioid treatment program–integrated facilitated telemedicine resulted in significantly higher HCV cure rates compared with off-site referral, with significant reductions in illicit drug use and minimal reinfections. ja.ma/4cEXwAF

Exciting News! AMERSA has just released our latest position statement: Methadone’s Resurgence in Bridging the Treatment Gap in the Overdose Crisis. Read the full position and recommendations here: amersa.org/advocacy-state…

New in JAMA Network Open 🚨 we show that initiation of meds for alcohol use disorder on hospital discharge is associated with ⬇️ 30-day ED visits and readmissions! 1/7 jamanetwork.com/journals/jaman…

Yesterday Center for Mental Health and Addiction Policy had a really important conversation in partnership with ONDCP on #methadone in correctional facilities with leaders from SAMHSA DEA HQ Washington Corrections AZ DEPT OF CORRECTIONS, REHABILITATION & REENTRY

The video is now available here: vimeo.com/928572282

1/n

Patients with addiction deserve rigorous evidence

We hope this article is helpful to others seeking to update and strengthen the evidence base around medications for opioid use disorder